Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02705404 · ClinicalTrials.gov registry record
A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 8
- Enrollment target
NCT02705404: Clinical Trial study, sponsored by Mayo Clinic.
NCT02705404 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02705404 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The investigators are doing this research to see if they can use small tissue samples or fluid to develop a test that will determine if the tissue samples are related or not related to each other. The test will use the patient's DNA, which is part of their unique genetic material that carries the instructions for the body's development and function. Cancer can result from changes in a person's genetic material that causes cells to divide in an uncontrolled way and, sometimes, to travel to other organs. Currently, researchers and doctors know some of the genetic changes that can cause cancer, but they do not know all of the genetic changes that can cause cancer.
Primary Outcome
Performance of the mate pair next generation sequencing lineage test on cytology and small biopsy specimens obtained as part of routine clinical practice, through either a bronchoscopic, CT-guided needle procedure, or lung resection as evidenced in receiving results from the sequencing.
Interventions
- GENETIC Multifocal Tissue Banking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-02-11 |
| Est. Completion | 2021-11-16 |
Why NCT02705404 stopped before completion
NCT02705404 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Multifocal Tissue Banking is the first listed.
NCT02705404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02705404 about?
NCT02705404 is a clinical study titled "A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing". The investigators are doing this research to see if they can use small tissue samples or fluid to develop a test that will determine if the tissue samples are related or not related to each other. The test will use the patient's DNA, which is part of their unique genetic material that carries the in...
What is the current status of trial NCT02705404?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2016-02-11. Estimated completion is 2021-11-16.
What interventions are being tested in trial NCT02705404?
The interventions under investigation include: Multifocal Tissue Banking (GENETIC).
Who is sponsoring clinical trial NCT02705404?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI